These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25446818)

  • 1. Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.
    Sørup S; Benn CS; Stensballe LG; Aaby P; Ravn H
    Vaccine; 2015 Jan; 33(1):237-45. PubMed ID: 25446818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
    Sørup S; Benn CS; Poulsen A; Krause TG; Aaby P; Ravn H
    JAMA; 2014 Feb; 311(8):826-35. PubMed ID: 24570246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
    Tielemans SMAJ; de Melker HE; Hahné SJM; Boef AGC; van der Klis FRM; Sanders EAM; van der Sande MAB; Knol MJ
    BMJ; 2017 Aug; 358():j3862. PubMed ID: 28855159
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study.
    Sørup S; Benn CS; Poulsen A; Krause TG; Aaby P; Ravn H
    Vaccine; 2016 Dec; 34(50):6172-6180. PubMed ID: 27840013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.
    Rieckmann A; Hærskjold A; Benn CS; Aaby P; Lange T; Sørup S
    Int J Epidemiol; 2019 Dec; 48(6):2026-2038. PubMed ID: 31062020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study.
    Sørup S; Stensballe LG; Krause TG; Aaby P; Benn CS; Ravn H
    Open Forum Infect Dis; 2016 Jan; 3(1):ofv204. PubMed ID: 26885538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
    Pedersen KB; Holck ME; Jensen AKG; Suppli CH; Benn CS; Krause TG; Sørup S
    Scand J Public Health; 2020 Feb; 48(1):96-105. PubMed ID: 30024308
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines for measles, mumps and rubella in children.
    Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden - An interrupted time-series analysis.
    Sørup S; Englund H; Laake I; Nieminen H; Gehrt L; Feiring B; Trogstad L; Roth A; Benn CS
    Vaccine; 2022 Mar; 40(11):1583-1593. PubMed ID: 33518465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial.
    Zimakoff AC; Jensen A; Vittrup DM; Herlufsen EH; Sørensen JK; Malon M; Svensson J; Stensballe LG
    BMJ; 2023 Jun; 381():e072724. PubMed ID: 37286215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revaccination With Measles-Mumps-Rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.
    Sørup S; Jensen AKG; Aaby P; Benn CS
    Clin Infect Dis; 2019 Jan; 68(2):282-290. PubMed ID: 29846533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
    Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
    BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study.
    La Torre G; Saulle R; Unim B; Meggiolaro A; Barbato A; Mannocci A; Spadea A
    Hum Vaccin Immunother; 2017 Aug; 13(8):1879-1883. PubMed ID: 28604255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses.
    Zimmermann P; Perrett KP; van der Klis FR; Curtis N
    Immunol Cell Biol; 2019 Jul; 97(6):577-585. PubMed ID: 30791143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.